Large Cell Neuroendocrine Carcinoma of the Bile Duct, a Case Report and Review of the Literature

• Published in: Nippon Shokaki Geka Gakkai zasshi Vol. 50; no. 1; pp. 33 - 42
• Main Authors: Kyogoku, Noriaki, Iwai, Kazuhiro, Yoshimi, Yasunori, Hosoi, Hayato, Matsui, Aya, Sato, Nagato, Hazama, Kazuaki, Watanabe, Mikio, Otsuka, Noriyuki, Hirano, Satoshi
• Format: Journal Article
• Language: Japanese; English
• Published: The Japanese Society of Gastroenterological Surgery 01.01.2017
• Subjects: bile duct; large cell carcinoma; neuroendocrine carcinoma
• ISSN: 0386-9768; 1348-9372
• DOI: 10.5833/jjgs.2015.0094

A 64-year-old man was admitted for epigastralgia. Abdominal CT showed an enhanced tumor at the lower biliary duct causing obstructive jaundice. Tumor cells with high nuclear-cytoplasmic (N/C) ratio and rosette formation were confirmed by biopsy. Immunostaining findings were positive for chromogranin A，synaptophysin, and neuron specific enolase. Preoperatively, we suspected neuroendocrine carcinoma (NEC) of the bile duct, and performed subtotal stomach-preserving pancreatoduodenectomy. Histological examination of the specimen demonstrated large cell NEC of the bile duct. The Ki-67 index was 40%. As adjuvant chemotherapy, tegafur-gimeracil-oteracil potassium was administered for 24 months, and he has no evidence of recurrence after surgery. NEC of the bile duct are rare and highly malignant diseases with a dismal prognosis. To the best of our knowledge, 50 cases of biliary NEC have been reported in Japan, and only 6 cases of biliary large cell NEC have been reported in the English literature. Analysis of reported cases indicates that curative resection can improve survival rate among patients with biliary NEC. Further evaluation is needed to elucidate optimal adjuvant therapy for biliary NEC.